PDL

  www.pdl.com
  www.pdl.com

PDL Reviews

4 Reviews
3.1
4 Reviews

Recommend to a friend
Approve of CEO
PDL President, CEO, and Director John P. McLaughlin
John P. McLaughlin
0 Ratings
  1.  

    Highly satisfactory

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Current Employee - Entry Level in Tuscaloosa, AL
    Current Employee - Entry Level in Tuscaloosa, AL

    I have been working at PDL full-time (less than an year)

    Pros

    In my assessment here work can be done with confidence and scope of creativity prevails there.

    Cons

    some people working there are not smart up to the mark

    Advice to ManagementAdvice

    Every worker should be honoured by their performance

    Recommends
    Positive Outlook
    No opinion of CEO

PDL Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.pdl.com
Headquarters Incline Village, NV
Size 150 to 499 Employees
Founded Unknown
Type Company - Public (PDLI)
Industry Biotech & Pharmaceuticals
Revenue $100 to $500 million (USD) per year
Competitors Amgen, XOMA, Seattle Genetics

If your body starts fighting you, PDL BioPharma hopes to help you fight back. The company's antibody (protein) humanization technology makes it possible to alter mouse monoclonal antibodies (MAbs) for use in human therapies, such as preventing and treating autoimmune diseases and cancer. The firm has licensed its technology to such companies as Genentech for therapies including Genentech's best-selling breast-cancer treatment MAb Herceptin. PDL derives nearly all of its revenues from royalties from products including Genentech's Herceptin and Avastin and Elan's Tysabri.

Work at PDL? Share Your Experiences

PDL

 
Click to Rate
or